Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is -41.24% vs 76.27% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is -30.36% vs 31.62% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is -32.69% vs 59.64% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is -22.22% vs 0.00% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024
Compare Quarterly Results Of GuiZhou SanLi Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is -28.14% vs -41.51% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -41.24% vs 76.27% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 0.94% vs -47.60% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -30.36% vs 31.62% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -11.26% vs -35.84% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -32.69% vs 59.64% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 12.90% vs -34.04% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -22.22% vs 0.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






